We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

180 hedge funds and large institutions have $691M invested in Immunogen Inc in 2017 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 18

28% more capital invested

Capital invested by funds: $542M → $691M (+$149M)

15% more funds holding

Funds holding: 157 → 180 (+23)

11% more call options, than puts

Call options by funds: $5.99M | Put options by funds: $5.38M

26% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 58

Holders
180
Holders Change
+23
Holders Change %
+14.65%
% of All Funds
4.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
41
Increased
43
Reduced
58
Closed
18
Calls
$5.99M
Puts
$5.38M
Net Calls
+$612K
Net Calls Change
-$2.02M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$20.1M
2
RG
Redmile Group
California
+$18.9M
3
Franklin Resources
Franklin Resources
California
+$18.7M
4
State Street
State Street
Massachusetts
+$13.5M
5
O
OrbiMed
New York
+$10M

Top Sellers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
-$9.48M
2
PAM
Panagora Asset Management
Massachusetts
-$4.21M
3
FCM
Farallon Capital Management
California
-$3.59M
4
Goldman Sachs
Goldman Sachs
New York
-$2.9M
5
BBA
Baker Bros. Advisors
New York
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$4.8M +$3.15M +473,666 +307%
EI
27
EAM Investors
California
$4.52M +$52.1K +7,843 +1%
CS
28
Candriam SCA
Luxembourg
$4.36M – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$4.2M -$195K -29,354 -5%
Renaissance Technologies
30
Renaissance Technologies
New York
$4.01M -$1.32M -198,000 -27%
CEP
31
Chicago Equity Partners
Illinois
$3.75M +$1.81M +272,315 +125%
RJA
32
Raymond James & Associates
Florida
$3.5M -$599K -90,163 -16%
Charles Schwab
33
Charles Schwab
California
$3.38M +$728K +109,547 +33%
Two Sigma Investments
34
Two Sigma Investments
New York
$2.9M +$2.2M +330,953 +683%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$2.58M -$90.4K -13,610 -4%
Norges Bank
36
Norges Bank
Norway
$2.56M – – –
Wellington Management Group
37
Wellington Management Group
Massachusetts
$2.38M +$2.07M +311,763 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$2.25M +$1.95M +293,748 New
Natixis Advisors
39
Natixis Advisors
Massachusetts
$2.19M -$50.2K -7,553 -3%
Fisher Asset Management
40
Fisher Asset Management
Washington
$1.9M -$50.7K -7,630 -3%
GAM
41
Gotham Asset Management
New York
$1.87M +$1.62M +243,949 New
Citigroup
42
Citigroup
New York
$1.86M -$2.63K -396 -0.2%
Allianz Asset Management
43
Allianz Asset Management
Germany
$1.78M +$1.55M +232,635 New
FIM
44
Fernwood Investment Management
Massachusetts
$1.69M +$13.3K +2,000 +0.9%
Ameriprise
45
Ameriprise
Minnesota
$1.59M -$65.2K -9,819 -4%
AIM
46
Alambic Investment Management
California
$1.56M +$1.1M +165,582 +436%
Citadel Advisors
47
Citadel Advisors
Florida
$1.53M +$1.33M +199,839 New
ACM
48
Avalon Capital Management
California
$1.49M +$1.29M +194,636 New
PPA
49
Parametric Portfolio Associates
Washington
$1.45M +$667K +100,455 +113%
ARTA
50
A.R.T. Advisors
New York
$1.27M +$1.1M +166,036 New
1
2
3 4 5

IMGN Hedge Fund Activity: Q3 2017 in Review

180 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2017, worth a combined $691M — up 28% from $542M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new IMGN positions and 18 closed out — a net gain of 23 holders — while 43 added to existing stakes and 58 trimmed.

The largest buyer was Vanguard Group, adding an estimated $20.1M. The largest seller was ClearBridge Investments, cutting an estimated $9.48M.

  • 180 institutional investors held Immunogen Inc (IMGN) as of Q3 2017, up from 157 in Q2 2017.
  • Funds reported $691M of Immunogen Inc stock for Q3 2017, up 28% quarter-over-quarter.
  • 41 funds opened new Immunogen Inc positions in Q3 2017 and 18 closed out, a net change of +23 holders.
  • The largest Immunogen Inc buyer in Q3 2017 was Vanguard Group, an estimated $20.1M added.
  • The largest Immunogen Inc seller in Q3 2017 was ClearBridge Investments, an estimated $9.48M sold.

Based on aggregated 13F filings for Q3 2017.